* M. R. Detty, Photosensitisers for the photodynamic therapy of cancer and other diseases, Expert Opin. Ther. Patents , 11:1849–1860, 2001 DOI:10.1517/13543776.11.12.1849
* T. J. Dougherty et al., Photodynamic therapy, J. Nat. Cancer Inst. , 90:889–905, 1998 [PMID: 9637138] DOI:10.1093/jnci/90.12.889
* B. W. Henderson and T. J. Dougherty, How does photodynamic therapy work?, Photochem. Photobiol. , 55:145–157, 1992 [PMID: 1603846] DOI:10.1111/j.1751-1097.1992.tb04222.x
* D. G. Hilmey et al., Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy, II. Effects of core heteroatoms and meso-substituents on biological activity, J. Med. Chem. , 45:449–461, 2002 [PMID: 11784149] DOI:10.1021/jm0103662
* J. L. Sessler and R. A. Miller, Texaphyrins—New drugs with diverse clinical applications in radiation and photodynamic therapy, Biochem. Pharmacol. , 59:733–739, 2000 [PMID: 10718331] DOI:10.1016/S0006-2952(99)00314-7
* W. M. Sharman, C. M. Allen, and J. E. van Lier, Photodynamic therapeutics: Basic principles and clinical applications, Drug Discovery Today , 4:507–517, 1999 DOI:10.1016/S1359-6446(99)01412-9